Literature DB >> 2768772

Alzheimer patient evaluation and the mini-mental state: item characteristic curve analysis.

J W Ashford1, P Kolm, J A Colliver, C Bekian, L N Hsu.   

Abstract

To develop a tool for precisely assessing dementia severity, items should be selected according to their relationship to the overall progression of the disease. Using an item characteristic curve analysis (ICC), items were examined from the Folstein Mini-Mental State Exam (MMSE), a useful clinical tool for evaluating dementia. MMSE data were available for 86 patients who met DSM-III criteria for primary degenerative dementia -- possible or probable Alzheimer's disease (AD). A logistic regression analysis of the probability of correct performance on an item, given the total MMSE score, yielded statistics for difficulty and discrimination. These statistics were interpreted respectively as indicators of the point in the progression of the illness at which the mental function tested by that item is lost and the rapidity of that loss. The data indicated a systematic progression of the development of symptoms in AD related to decline of memory function. Temporal orientation was lost before spatial and object orientation, and recollection of words was lost before ability to repeat them. ICC can help to delineate the loss of mental functions during the course of AD.

Entities:  

Mesh:

Year:  1989        PMID: 2768772     DOI: 10.1093/geronj/44.5.p139

Source DB:  PubMed          Journal:  J Gerontol        ISSN: 0022-1422


  27 in total

1.  Mini-Mental State Examination (MMSE): sensitivity in an Italian sample of patients with dementia.

Authors:  M Mazzoni; L Ferroni; L Lombardi; E Del Torto; M Vista; P Moretti
Journal:  Ital J Neurol Sci       Date:  1992-05

2.  Neighborhood social stressors, fine particulate matter air pollution, and cognitive function among older U.S. adults.

Authors:  Jennifer Ailshire; Amelia Karraker; Philippa Clarke
Journal:  Soc Sci Med       Date:  2016-11-14       Impact factor: 4.634

3.  Fine particulate matter air pollution and cognitive function among U.S. older adults.

Authors:  Jennifer A Ailshire; Philippa Clarke
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2014-06-06       Impact factor: 4.077

Review 4.  Modeling the time-course of Alzheimer dementia.

Authors:  J W Ashford; F A Schmitt
Journal:  Curr Psychiatry Rep       Date:  2001-02       Impact factor: 5.285

5.  Time estimation in mild Alzheimer's disease patients.

Authors:  Luana Caselli; Luca Iaboli; Paolo Nichelli
Journal:  Behav Brain Funct       Date:  2009-07-28       Impact factor: 3.759

6.  Fine particulate matter air pollution and cognitive function among older US adults.

Authors:  Jennifer A Ailshire; Eileen M Crimmins
Journal:  Am J Epidemiol       Date:  2014-06-24       Impact factor: 4.897

7.  The MMSE orientation for time domain is a strong predictor of subsequent cognitive decline in the elderly.

Authors:  Elizabeth Guerrero-Berroa; Xiaodong Luo; James Schmeidler; Michael A Rapp; Karen Dahlman; Hillel T Grossman; Vahram Haroutunian; Michal Schnaider Beeri
Journal:  Int J Geriatr Psychiatry       Date:  2009-12       Impact factor: 3.485

8.  Associations of Subjective Memory Complaints and Simple Memory Task Scores With Future Dementia in the Primary Care Setting.

Authors:  Lennard L van Wanrooij; Edo Richard; Susan Jongstra; Eric P Moll van Charante; Willem A van Gool
Journal:  Ann Fam Med       Date:  2019-09       Impact factor: 5.166

9.  Psychometric properties of Addenbrooke's Cognitive Examination III (ACE-III): An item response theory approach.

Authors:  Carlos Calderón; Christian Beyle; Oscar Véliz-García; Juan Bekios-Calfa
Journal:  PLoS One       Date:  2021-05-06       Impact factor: 3.240

10.  Quality of life as an outcome in Alzheimer's disease and other dementias--obstacles and goals.

Authors:  Matthias W Riepe; Thomas Mittendorf; Hans Förstl; Lutz Frölich; Martin Haupt; Reiner Leidl; Christoph Vauth; Matthias Graf von der Schulenburg
Journal:  BMC Neurol       Date:  2009-08-25       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.